Viewing Study NCT03843034


Ignite Creation Date: 2025-12-25 @ 2:28 AM
Ignite Modification Date: 2026-03-04 @ 7:06 PM
Study NCT ID: NCT03843034
Status: UNKNOWN
Last Update Posted: 2023-11-02
First Post: 2019-02-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Endometrial Markers in Autoimmune Diseases
Sponsor: Odense University Hospital
Organization:

Study Overview

Official Title: Endometrial Markers in Women With Autoimmune Diseases Receiving Assisted Reproduction
Status: UNKNOWN
Status Verified Date: 2023-11
Last Known Status: ACTIVE_NOT_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Autoimmune diseases cause a decreased endometrial receptivity during the implantation window, most likely changing the endometrial cytokines pattern due to dysregulation of the inflammatory processes.Therefore, endometrial cytokine profiles will be compared in women with autoimmune disease and normal, fertile women.

The collected endometrial tissue and blood samples will be examined for the cytokines profiling using commercially available ELISA kits.

The sample size was calculated choosing, as primary outcome, changes in endometrial LIF concentration between the disease and control Group, which is our main goal. Given a type I error of 5%, a maximum of 21 women are needed for each Group to reach the desired power of 80% to detect the least changes in concentrations.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: